Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHEMI SPA

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 54
  • 0 comments

FDA approve TEMOZOLOMIDE

Comment Full text

CIPLA

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 52
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 54
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

SANDOZ

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 54
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; TRIAMTERENE

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 43
  • 0 comments

FDA approve TAZAROTENE

Comment Full text

PRINSTON INC

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 54
  • 0 comments

FDA approve PAROXETINE HYDROCHLORIDE

Comment Full text

SANDOZ INC

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 49
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

CHARTWELL RX

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 55
  • 0 comments

FDA approve AZITHROMYCIN

Comment Full text

CHARTWELL RX

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 53
  • 0 comments

FDA approve AZITHROMYCIN

Comment Full text

ANI PHARMS

  • FDA Approval
  • July 17, 2024, 12:52 UTC
  • 59
  • 0 comments

FDA approve RISPERIDONE

Comment Full text
  • Previous
  • 394
  • 395
  • 396
  • 397
  • 398
  • Next

Search

News categories

  • Technical Exchange News(14659)
  • Event(6229)
  • SEC News(391532)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(238837)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin